secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0001654954-23-008880
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZIVO Bioscience raises ~$4.0M in registered direct offering and concurrent private placement
--------------------------------------------------------------------------------

- Sold 1,498,130 shares/pre-funded warrants at $2.67/unit to institutional investor for ~$4.0M gross proceeds.
- Concurrent private placement of Series A (2-yr) and Series B (5-yr) warrants exercisable for 1,498,130 shares each at $2.80.
- Offering expected to close July 5, 2023; Maxim Group LLC is sole placement agent.
- Shares offered under effective S-3 registration; warrants unregistered under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423008880/0001654954-23-008880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423008880/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-008880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer